Trade Summary

Yesterday, Parschauer Karah Herdman, serving as EVP and Chief Legal Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,900 shares at $24.92 per share, for a total transaction value of $47,348.00. Following this transaction, Parschauer Karah Herdman now holds 92,562 shares of RARE.

This sale represents a 2.01% decrease in Parschauer Karah Herdman's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, August 3, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, August 4, 2026 at 3:15 PM ET, 1 day after the trade was made.

Ultragenyx Pharmaceutical Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.